Columnist and caregiver Sylvia Amuta shares the top pain management strategies that help her young cousin cope with sickle ...

Enrollment has finished for the Phase 3 RISE UP study, which is testing the oral therapy mitapivat in people with sickle cell ...

Approved in India as Oxemia for anemia, desidustat stimulates erythropoietin, a signaling molecule secreted in response to ...

Enlargement of the heart’s left upper chamber in sickle cell patients is associated with worse disease severity, per a new ...

Preschool-aged children with sickle cell disease with limited access to healthy food and transportation are at higher risk ...

Women with SCD experience significant healthcare challenges, a study found, with researchers calling for training on ...

Women with sickle cell disease (SCD) experience significant challenges with healthcare while struggling with both the ...

Columnist Oluwatosin Adesoye reflects on her thriving life as she turns 38 (and counting) with sickle cell disease.

Wilson explains how Pfizer's decision to withdraw Oxbryta from global markets could affect the sickle cell community.

Mitem Pharma has acquired worldwide rights to Desferal (deferoxamine), a therapy commonly used to lower excessive and damaging iron levels induced by blood transfusions in people with sickle cell ...